Cyclosporin A and rapamycin are each used as T cell immunosuppressants. They share the property of binding to immunophilin molecules in T cells as the initial step in their mechanisms of action. However, in the case of cyclosporin A, the drug:immunophilin complex binds to and inhibits the protein phosphatase calcineurin, whereas the rapamycin:immunophilin complex binds to and inhibitors mTOR. As a consequence,
A) Cyclosporin A, but not rapamycin, blocks cytokine production by T cells.
B) Both cyclosporin A and rapamycin block cytokine production by T cells.
C) Rapamycin, but not cyclosporin A, blocks T cell proliferation.
D) Neither rapamycin nor cyclosporin A block T cell proliferation.
E) Both cyclosporin A and rapamycin inhibit co-stimulatory signaling through CD28 on T cells.
Correct Answer:
Verified
Q1: In the first few days following organ
Q3: Immune responses to tumors have been studied
Q4: Mycophenolate mofetil is a cytotoxic drug that
Q5: The vitamin D3 metabolite 1,25(OH)2D3 binds
Q6: A recent strategy showing some promise for
Q7: Immunotoxin therapy as an anticancer treatment is
Q8: Corticosteroids are anti-inflammatory drugs that are used
Q9: Immunotherapies aimed at promoting anti-tumor immune responses
Q10: Abatacept is a biologic drug that is
Q11: Natalizumab is a humanized monoclonal antibody
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents